
Osteochondral tissue engineering‑based subchondral bone plate repair (Review)
- Authors:
- Published online on: April 4, 2025 https://doi.org/10.3892/mmr.2025.13517
- Article Number: 152
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Articular cartilage is a durable tissue capable of load transmission and articulation of joints. It is primarily composed of hyaline cartilage, which provides low friction and shock absorption in synovial joints (1). Hyaline cartilage benefits from the presence of collagen (Col)-II-based dense extracellular matrix (ECM), which provides resistance against complex loading patterns including compression, shear and friction (2). Together, the upper articular cartilage, subchondral bone plate (SBP) and underlying trabecular bone create an intact structural and functional osteochondral unit (Fig. 1) (3).
There are a number of ways to evaluate osteochondral regeneration, including the International Cartilage Repair Society, Wakitani and O'Driscoll scoring systems (4,5), all of which place greater emphasis on cartilage regeneration. However, the evaluation of subchondral bone repair has been less thoroughly investigated (4,5). Subchondral bone consists of two anatomical entities, the SBP and trabecular bone. The SBP is a thin cortical bone plate with a permeable porous structure located beneath the calcified cartilage (3). The cancellous bone structure within the trabecular bone is located beneath the SBP. The porous structure in subchondral bone provides nutritional support to the osteochondral unit through numerous nerves and vessels. Currently, osteoarthritis-related subchondral bone damage is a highly prevalent pathological condition. The supply of blood and nutrients is limited after injury and osteoarthritis has a major adverse impact on the preservation of osteochondral unit function. Thus, subchondral bone regeneration requires further recognition and investigation.
Osteochondral defects are a considerable symptomatic and functional burden to patients and lead to decreased quality of life. In particular, younger patients lack long-term treatment solutions, may require numerous surgeries and may experience unwanted effects throughout their lives because of the inevitable progression of osteoarthritis (6). Various clinical strategies and techniques have been developed to improve repair efficacy. These can be classified into bone marrow-stimulating techniques (drilling, abrasion and microfracture), direct chondral replacement (mosaicplasty and osteochondral allograft transplantation), cell culture-based treatment [autologous chondrocyte implantation (ACI), matrix-induced autologous chondrocyte implantation (MACI)] and total joint arthroplasty (7,8) (Fig. 2B). Total joint arthroplasty is considered to be the most useful strategy for both cartilage and bone repair (9). Although the aforementioned treatments are common clinical procedures, obvious drawbacks and limitations remain for long-term joint preservation (7,8).
Microfracture treatment involves drilling tiny holes that permit the cartilage and subchondral bone to take blood and bone marrow components from the underlying tissues (7). This induces cartilage and bone regeneration/remodeling following the introduction of stem cells and biomolecules at the defect site (9). However, the procedure may lead to the formation of fibrocartilage, which has inferior biofunctional and mechanical properties compared with hyaline cartilage (10). Similarly, use of ACI and MACI commonly results in the production of fibrocartilage rather than hyaline cartilage, which hinders the joint from recovering normal function (3). For 20 years, articular cartilage has been successfully regenerated using ACI, with positive surgical results. Nevertheless, drawbacks remain, including a shortage of chondrocyte sources, long chondrocyte harvesting time, difficulty of chondrocyte solution fixation, periosteal hypertrophy and ablation (10), as well as limited effectiveness in aged patients. Also, osteochondral lesions require simultaneous healing of the subchondral bone, which ACI cannot repair (8,11). Allografts have numerous disadvantages, including limited tissue supply, immune rejection, insufficient host-graft integration, low cell viability due to graft storage and potential for disease transmission (12). Osteochondral autografts may be able to overcome the shortcomings of allografts; however, insufficient integration and a deficient tissue source, additional surgery and donor site morbidity limit extensive clinical application (10). For cell culture-based treatment, technical disadvantages such as poor preparation of cell sources, donor site morbidity, inadequate time for cell expansion, poor retention and de-differentiation of cultured cells, decline of intrinsic activity and functionality of senescent cells, as well as inconsistent quality control for large-scale cell production may block progression of mesenchymal stem cell or chondrocyte transplantation (12). Consequently, more sophisticated treatments that take different architecture and regeneration potential into account, namely structurally and functionally biomimetic tissue-engineered strategies, have emerged as promising options for the simultaneous regeneration of subchondral bone and cartilage lesions (Table I).
Significant progress has been made in the field of tissue engineering over the last two decades with numerous studies demonstrating the construction of de novo cartilage and bone both in vitro and in vivo (13). The three important components involved in the tissue engineering of osteochondral grafts are biomaterials, cells and growth factors (Fig. 2A). Currently, very few studies focus specifically on the reconstruction of the SBP during osteochondral regeneration. However, a growing body of research suggests that creating the right microenvironment using tissue engineering approaches and further stimulating SBP regeneration are essential for regenerating the entire osteochondral unit (14–16). Incorporating the three components aforementioned into the process should provide the conditions required to establish the ideal microenvironment and heal the osteochondral lesion.
Achieving satisfactory osteochondral regeneration in small animal models does not guarantee success in large animal models. As both the joint size and the burden increase, osteochondral regeneration must meet the mechanical demands of the new tissues. SBP regeneration, an important indicator of recovery from osteochondral stiffness, may predict the performance of tissue-engineered osteochondral grafts during the translational process. However, very few studies have examined SBP regeneration and almost all have only evaluated the methodology descriptively.
The present study reviewed in vivo osteochondral repair with tissue-engineered osteochondral grafts. This includes i) summarizing the design of tissue-engineered osteochondral grafts to demonstrate their role in promoting osteochondral regeneration in terms of cells, scaffolds and growth factors, with a focus on the regeneration of SBPs. ii) Discussing both normal histology and SBP reconstruction. iii) Summarizing current limitations and challenges associated with SBP regeneration during osteochondral defect repair to guide future translational research and accelerate the ‘bench to bedside’ process.
Evaluating SBP regeneration
Defining satisfactory SBP repair
Histological assessment is commonly employed to evaluate osteochondral tissue regeneration. The regenerated tissue, including the SBP, is compared with corresponding host tissue to further assess repair quality. In addition, microcomputed tomography (µ-CT) is an acknowledged ‘gold standard’ for SBP evaluation, with its global view of bone architecture providing a detailed assessment. However, criteria for satisfactory SBP regeneration have not been established. Typical SBPs share common features, such as a suitable height, a flat and smooth surface, good interface integration and dense texture (17); SBP regeneration is not considered successful unless all four features are present. Other literature has summarized the histological scores of SBP repair by scoring abnormal activity following the repair (18). The standard for scoring abnormal activity is that a SBP with a low score has good mobility and good mechanical properties. However, a low score for repaired SBP is not representative (18), because few studies have used this scoring system and it cannot quantify performance appropriately.
Typical indicators of insufficient/unsatisfactory SBP repair
In contrast to the aforementioned four criteria for adequate SBP regeneration, the four typical indicators of a failed repair are abnormal height, uneven surface, poor integration and loose lacunae structure (Fig. 3). When three or more indicators are present, defects filled with fibrous tissue have been reported, along with either tissue resembling collapsed cartilage or scarcely any cartilage regeneration. When one or two indicators were found in the repaired SBP, regenerated hyaline cartilage with sufficient integration with surrounding host cartilage was observed (Fig. 3). while a plate with one or two indicators of failure was defined as a moderate repair. Among these four indicators of failed repair, abnormal height was the most frequent. Moreover, when abnormal height was apparent, it was often accompanied by two or three other indicators, which suggests that abnormal height has a clear influence on SBP repair and that SBP may be required to reach an appropriate height during regeneration. These four histological findings provide a path to understanding the underlying causes of inadequate osteochondral regeneration from the perspective of the SBP.
Cell selection for tissue-engineered osteochondral grafts
Cells with specific differentiation and proliferation capacities are used in osteochondral tissue engineering. Bone marrow-derived mesenchymal stem cells (BMSCs) are the most common seed cells used in both monolayer and multilayer grafts. BMSCs can differentiate into various cell types, including osteocytes and chondrocytes, which then form osteochondral units (19). Adipose-derived stem cells (ADSCs) are another important source of stem cells for osteochondral transplants. Along with chondrogenic potential, ADSCs have demonstrated extraordinary potential for invasion, migration and proliferation (19) and provide a suitable microenvironment for osteochondral regeneration. In addition to stem cells, somatic cells are also used. Chondrocytes are the primary option as they promote chondral portion regeneration in osteochondral grafts (8,11,14) (Fig. 4). Recently, genetically modified cells were introduced in osteochondral tissue engineering (13,20). These cells upregulate gene expression, thus promoting cell proliferation or differentiation.
Cells for cartilage repair
One of the most significant functions of seeding cells is to promote the regeneration of cartilage. Research has indicated that BMSCs have a distinct advantage over ADSCs in cartilage repair because of their greater capacity for cartilage differentiation (21,22). Compared with chondrocytes, BMSCs can produce ECM with higher mechanical strength (21,22). However, the aforementioned advantages do not consider the effect of the graft itself. When widely applied to osteochondral grafts, BMSCs occasionally result in the formation of fibrocartilage instead of hyaline cartilage (23). This unsatisfactory repair should not be attributed to the cell type since the same limited cell types are used in bilayer and trilayer grafts. The bilayer graft, which is usually composed of chondrogenic and osteogenic layers, resembles a normal osteochondral unit, with the top layer encouraging cartilage repair. BMSCs can be inserted into the cartilage layer to restore the ECM. Alternatively, chondrocytes can be implanted in the chondrogenic layer to improve chondrogenesis because of their outstanding ability to synthesize cartilage matrix (22). Similarly, BMSCs and chondrocytes are utilized in trilayer or multilayer grafts for cartilage regeneration. Under these circumstances, the neocartilage is always reconstructed with firm and compact cell lineage. BMSCs and chondrocytes have significant potential to promote cartilage regeneration in both bilayer and multilayer grafts.
Cells for trabecular bone repair
Although bone regeneration appears easier than cartilage regeneration over an extended period, bone tissue reconstruction must be relatively rapid and provide early support for superficial chondral tissue regeneration (24,25). For this purpose, cells were incorporated into tissue-engineered grafts to adjust the speed of bone reconstruction. BMSCs have been widely used in this process because of their self-renewal and differentiation capacities (1). Other studies have reported the use of periosteum-derived progenitor cells, which can induce the formation of subchondral bone. These cells can also stimulate differentiation of mineralized bone tissue and bone marrow (Fig. 4) (19,26). Furthermore, osteoblasts in the underlying layer of bone can promote the growth, differentiation and infiltration of new bone (27) and are mainly responsible for the synthesis, secretion and mineralization of bone matrix (19). When cultured on osteochondral tissue grafts, the regenerated bone tissue stimulated by osteoblasts is firm with good mechanical properties.
Cells for SBP repair
No existing literatures discuss the function of a certain cell to promote the regeneration of SBP exclusively, as SBP is often regarded as part of subchondral bone. Previous studies viewed that cells which can regenerate bone certainly can repair SBP (28–30). However, the SBP can be satisfactorily rebuilt when specific cell types are incorporated into a well-integrated graft that contains growth factors. It has been found in previous studies that BMSCs embedded in bi-layer or tri-layer grafts can obtain flat and compact SBP regeneration (28–30), which no is doubt related to the polypotent and powerful differentiation potential of BMSCs (22). Others have shown that ADSCs can achieve good SBP regeneration after implantation in bi-layer grafts (28–30). Besides these pluripotent stem cells, chondrocytes may have the similar function to repair SBP (24). A flat and neat SBP structure well integrated with surrounding tissues can be detected. This is also closely related to the chondrocyte's function of secretion, synthesis and induction of calcified cartilage matrix (22). Previous research revealed that the regeneration of the SBP could not be independently stimulated by any one cell type, including stem cells or somatic cells. In general, SBP, cortical bone above trabecular bone, can usually achieve ideal repair results right after subchondral trabecular bone is well repaired (Table II).
Subsequent research revealed that the biocompatibility of the three-layer/multi-layer graft with the typical osteochondral unit structure gave it unique benefits in the repair of osteochondral lesions. Three-layer graft, distinguished from the two-layer graft, adds a transition layer between the chondrogenesis layer and the osteogenesis layer. It was expected that the SBP would undergo good regeneration when the cells were grown into the transition layer (30). Some stem cells with osteogenic potential, such as BMSCs and ADSCs, are commonly applied into the translational layer. For instance, these investigations all share the construction of the calcified cartilage layer (CCZ) and the successful SBP regeneration that results from the addition of BMSCs to the CCZ (31–33). On the other hand, the SBP typically heals poorly if these cells are denied access to the intermediate transition layer (30). These results can prove that osteogenesis is one of the necessary factors for the SBP. The trabecular bone structure can provide a stable biomechanical environment and mechanical support for the regeneration of the SBP. Also, translational layer of grafts provides enough space to accommodate neo SBP.
Scaffold design for osteochondral repair
Monolayer scaffold design
As a pivotal part of tissue engineering strategy, seeding cells can promote regeneration of the osteochondral unit, but cannot be effective without supportive scaffolds. The critical concept of the supportive scaffold design is to induce cell growth, proliferation and differentiation at the defect sites (34). As research rapidly progressed, monolayer scaffolds were the first to be designed and studied. Owing to their inherent limitations, monolayer grafts cannot regenerate the entire osteochondral structure; instead, their primary goal is to stimulate cartilage regeneration (35–37). The most recent tissue engineering approaches for the development of monolayer scaffolds include acellular cartilage matrix (ACM) and hydrogels, which are shown in Fig. 5 (38–41). Of these, ACM is the most frequently used material (38–41) because cartilage matrix clearly promotes cartilage regeneration and has demonstrated the ability to mimic various distinctive requirements of an ECM-like microenvironment. Hydrogels can be made from natural or synthetic polymers, depending on their unique characteristics and specific functions (36). They both offer conditions suitable for cell proliferation and differentiation. Hydrogels based on natural polymers including silk fibroin protein, sodium alginate, porous chitosan and hyaluronic acid have been extensively documented (41–45). Widely reported synthetic polymers include polycaprolactone (PCL), poly lactic-co-glycolic acid (PLGA) and polyurethane (43). These hydrogels are often a good choice for scaffold design due to good biocompatibility and biodegradability (46). In addition to these single-component hydrogel scaffolds, other scaffolds using combinations of two or more biomaterials, such as sodium alginate-gelatin, collagen-fibroin, hyaluronic acid-chitosan, have been used (23,29,47–49). These composite scaffolds are not only more beneficial to cartilage reconstruction but also markedly enhance the biomechanical properties of scaffolds (47). However, only a portion of cartilage tissue may be restored by monolayer grafts and subchondral bone is frequently disregarded (35,50). Although monolayer grafts do not appear to improve the repair of osteochondral lesions, their creation provides a foundation for additional study and the development of bi- and trilayer grafts.
Bilayer scaffold design
Typically, monolayer grafts only partly repair the defect and cannot achieve overall regeneration of the osteochondral unit. Due to the distinct mechanical strengths and biological environments of the cartilage and bone layers, the design of bilayer scaffolds is much more complicated. The cartilage layer of bilayer scaffolds shares a common structure with monolayer scaffolds, that is, polymer and ACM hydrogels (18,47,51). Due to the robust mechanical properties, excellent biocompatibility and slow biodegradability, cartilage regeneration was evident (38) and the arrangement of newly formed chondrocytes was similar to natural cartilage (52,53). The design of the osteogenesis layer of the bilayer scaffold is also important. To provide a suitable microenvironment and ensure bone regeneration, hydrogels and some inorganic materials became the main source for the osteogenesis layer (54–56). Commonly used materials, including bioceramics and bioglass (54–56), have been improved over the past few decades, with excellent osteoconductive and inductive properties, stiff mechanical strength and extraordinary biodegradability, allowing these materials to demonstrate superiority for subchondral bone repair (54). The osteogenesis layer of scaffolds constructed with hydroxyapatite (HAp) (57) show good bioplasticity (58) and a pattern similar to trabecular bone structure can be shaped using three-dimensional (3D) printing and other technologies. Bilayer scaffolds tend to achieve better repair results for both the cartilage layer and the subchondral bone layer compared with monolayer scaffolds.
Among bilayer graft studies, only a few reported that the SBP regenerated with an uneven surface or anomalous tissue formation between the cartilage and subchondral bone layer (58–60). At present, however, no phase of bilayer scaffolds has been developed that can precisely repair the SBP. Nonetheless, it has been demonstrated that offering a somewhat stable 3D microenvironment allows the bilayer scaffold to accomplish SBP regeneration (58). Proper porosity is one of the key conditions for creating a microenvironment and is also important for scaffold design (61,62). Relevant studies have reported that bilayer scaffolds with specific porosities can enhance SBP regeneration (55,63–65). Using different porosities, the microenvironment can support the growth and multiplication of encapsulated seeding cells as well as osteogenic and chondrogenic differentiation and can also improve structural stability and enhance mineralization in the subchondral bone region (66,67). For example, a bilayer scaffold with an upper porosity of 200 µm and a lower porosity of 400 µm (66,67) provided clear evidence of improving SBP regeneration (68). Although it is not entirely convincing to rely solely on designing different porosity to achieve SBP regeneration (55), these designs provide insight into how best to repair the SBP. If trilayer or multilayer scaffolds achieve unsatisfactory reconstruction, porosity may be a potential target to improve the SBP regeneration.
Trilayer/multilayer scaffold design
Trilayer grafts are designed based on bilayer grafts. The biggest advantage of the trilayer design is that it addresses the structural flaws in bilayer grafts by incorporating more structure into the graft. A transitional layer between the cartilage and bone layers often plays a pivotal role, with its functions including isolation of components and provision of a physicochemical barrier, cross-linking network and mechanical support (69). These grafts have two types of components; one that is similar to the composition of cartilage and another similar to the composition of bone (31,34). For the cartilage-like phase, Col-II-based scaffolds have been the most used. A dense isolated layer produced by Col-II/PLGA, with a small enough pore size and porosity, prevents excessive downward cartilage growth (34) and at the same time inhibits bone hyperplasia and hypertrophy (70). Others synthesized the calcified cartilage layer with Col-II/HAp and Col-I/HAp as a transitional layer (71) that served as a vital physical barrier, separating nutrients and cells within their respective spaces, avoiding crosstalk and interference between the cartilage and subchondral bone layers and ensuring a distinction between the cartilage and bone environments (72). For the bone-like phase, bioceramic was the most common material. PCL-β-tricalcium phosphate is a prepared transitional layer that has been reported to match the local Young's modulus in the middle and also provides steady support with excellent mechanical properties (31). Additionally, this transitional layer may offer sufficient space to regenerate the SBP. Trilayer scaffolds reported in the literature thus distinguish themselves from bilayer scaffolds. Together with the creation of stable cartilage and trabecular bone structures, trilayer tissue-engineered osteochondral grafts yield good repair of the SBP.
Compared with trilayer grafts, multilayer grafts could provide a more sophisticated structure to promote SBP regeneration (70,73). Typically, multilayer grafts are multifunctional, with each layer capable of performing a distinct function. Of those reported, the most common type includes a top layer promoting cartilage regeneration, a second calcified cartilage layer, a third transitional layer and a bottom layer that mainly mimics the porous structure of trabecular bone (33). This complex architecture creates a biomimetic environment for the entire osteochondral tissue (74). The calcified cartilage layer not only balances the differential physical load between upper cartilage and lower subchondral bone (34), but also helps stabilize the overall mechanical properties of the scaffold. In addition to the isolation and barrier function aforementioned (34), the intermediate transitional layer can release growth factors to the upper and lower layers of the scaffold (75). Notably, in both small and large animals, SBP regeneration results were good with a flat and even surface achieved (30,33,76). In general, the closer the structure of the artificial scaffold is to normal osteochondral structure, the more improved the repair efficacy. Multilayer grafts may thus result in improved osteochondral unit regeneration compared with bilayer grafts.
Given the complex structure of multilayer scaffolds, fabrication techniques have limited their progress. 3D printing has become a standard technique for fabricating biomimetic scaffolds. To date, a variety of 3D printing methods such as fused deposition modeling (FDM), inkjet printing, light-assisted bioprinting (digital light processing), stereolithography and laser-based printing have been used to engineer different tissue repair scaffolds (67,68) (Fig. 5). To mimic the structural and mechanical characteristics of subchondral bone and improve the hydrophilicity of the bone scaffold, some previous researchers fabricated the core-sheath structure bone layer using FDM (30). Other researchers have produced the chondral and osteochondral phases with 3D bioplotting; these have been designed with a cross-linking network and high porosity (71,73). These structures had surprising biocompatibility and could be adjusted according to the lesion position. Moreover, with 3D printing technologies, the fabrication of patient-specific scaffolds that perfectly match the size and shape of the defect would come true. And targeting porosity, layers, integration would be designed by 3D-printing technology, all these provide the possibility for future customized strategies. Consequently, multilayer scaffolds are unquestionably of higher quality because of 3D printing. Moreover, additional techniques for multiphase scaffolds are anticipated in the future.
Non-layer/gradient scaffold design
Gradient scaffolds have gained increasing popularity over the past decades. Gradient scaffolds involved two types: Compositional gradient scaffolds and structural gradient scaffolds (77). First, as with other kinds of stratified scaffolds, the materials applied in gradient component scaffold included collagen or extracellular matrix (77–79) and inorganic polymers such as PCL, PLGA and gelatin methacryloyl (GelMA) (80,81): With their suitable biodegradability and mechanical properties, scaffolds physicochemical stability could be sustained continuously (77). In contrast to stratified scaffolds, the primary characteristic of gradient scaffolds was the smooth transition between layers. Gradient scaffolds can prevent sudden component changes in distinct zones since the components in the osteochondral micro-environment vary gradually as depths increased (81). A gradient component scaffold was designed with PLGA/TCP and the upper cartilage layer was constructed of a microtubule-like structure. These microtubules were interconnected and parallel arranged in perpendicular plane (diameter, 84.2±20.7 µm). The bone layer had a highly interconnected porous structure with large pores (450.5±47.2 µm) (76). The whole osteochondral structure was repaired integrally and both cartilage layer and trabecular bone layer showed perfect reconstruction. Other studies have also proposed a biodegradable hydroxyapatite-collagen (HAp/Coll) gradient distribution scaffold with collagen matrix synthesized in four different weight ratios as follows: 0:100, 10:90, 30:70 and 50:50 to simulate the normal amount of cartilage and bone components (82). As well as cartilage and trabecular bone regeneration, regeneration of SBP could be also detected (82). The special benefits of the compositional gradient scaffold, structural stability, a biocompatible interior environment and successive compositional alteration, were the main reason of all these satisfactory results (77,82).
Microsphere scaffolds, another common construction prototype as gradient scaffolds, organize a three-dimension and porous structure for cells proliferation and tissue formation. In addition to the inherent advantages such as biocompatible structure and smooth translation between layers, the microsphere scaffolds show unique features to repair osteochondral defect. First is the architectural and mechanical variations throughout their 3D structure. Chitosan/mesoporous silica nanoparticles was designed as microsphere scaffold by Yuan et al (83). The nanoparticles possess excellent bio-remodeling activity, different patterns can be arranged in the chondrogenesis zone and osteogenesis zone. With their 3D structure and porous formation, the differentiation of chondrocytes can be obviously promoted (83) (Fig. 5). By adjusting the arrangement of nanoparticles, the mechanical properties of the scaffolds can mimic the transition from soft cartilage tissue to the calcified cartilage and ultimately subchondral bone (84). Along with the feasibility of nanoparticles, osteochondral defects could gain regeneration. The second characteristic of microsphere scaffolds is their ability to create interfacial cohesiveness between several layers. PCL/HA was used to construct a composite microsphere scaffold by Gu et al (85). Due to their tiny spherical 3D structure, these microspheres have the potential to improve scaffold transitions while also strengthening the interface integration (77). Regeneration of cartilage and bone tissue was observed following implantation of these microsphere scaffolds (84,85). With their unlimited and promising prospect, the design of gradient grafts will be markedly improved. After long-term observation and evaluation, the satisfactory result of osteochondral repair would be achieved with the gradient grafts application.
Growth factors for osteochondral repair
Incorporation of therapeutic growth factors into tissue-engineered grafts allows modulation of the local microenvironment (making it chondro- or osteo-inducive), which improves differentiation and increases matrix production (86,87). The transforming growth factor-β (TGF-β) superfamily includes TGF-β, bone morphogenetic protein (BMP) and growth differentiation factors. Of these, TGF-β3, TGF-β1 and BMP-2 are the three most widely used (86–88). TGF-β has a stimulatory effect at the early stage of chondrogenesis, promoting cartilage matrix synthesis, cell proliferation and upregulation of chondrogenic-specific genes (86,87). Moreover, it inhibits the terminal differentiation of hypertrophic chondrocytes (5). BMP-2 can stimulate bone regeneration by promoting the deposition of Col-I, inducing osteocyte differentiation and initiating angiogenesis in trabecular bone (89). In addition to the TGF superfamily, other frequently used growth factors include insulin-like growth factor-1, fibroblast growth factor and platelet-derived growth factor (PDGF) (19,26,36,50,90). Their functions include stimulating cell proliferation, triggering chondrogenesis gene expression and regulating apoptosis (36,50). Additionally, PDGF is important for vascularization, since it induces angiogenesis, regulates cell migration and supports vessel maturation and stabilization.
These growth factors can encourage the regeneration of cartilage or trabecular bone, but their specific efficacy in promoting SBP regeneration has not yet been reported. There are circumstances in which the SBP may be repaired. The plate is composed of cortical bone tissue (91). Growth factors, which can stimulate the repair of trabecular bone, can similarly regenerate the SBP. BMP encapsulated into the osteogenic layer contributes to the regeneration of the SBP (19) not only because of its excellent osteogenic differentiation properties, but also because of its ability to maintain homeostasis in the joint (19,33,36). Furthermore, SBP repair can be indirectly accomplished if the bone and cartilage layers are repaired together. Multilayer scaffolds encapsulating TGF-β1 and BMP-2 induce more uniform osteochondral tissue regeneration than scaffolds without growth factors (19,33,75). This indirectly stimulates the regeneration of the SBP. Use of growth factors may prove to be a useful strategy for SBP regeneration, despite the lack of evidence of a direct role for growth factors in SBP repair (Table III).
Translating animal models for SBP repair
Animal studies are an important stage between in vitro studies and clinical application. The choice of an appropriate animal model is fundamental to making appropriate conclusions (92). Animal studies usually include two groups according to size, small animal models and large animal models (Table IV). Small animal models, including rabbit, rat, dog and mouse models, are widely used in preclinical studies. These smaller models are low-cost, easy to handle and house and studies are easy to implement (5). Rabbits are the most used small animal model. Short- and long-term evaluations can be performed easily due to their light weight, robust exercise capacity and low load on the defect location (5). Compared with small animal models, large animal models, including pig, sheep, goat and horse models, have the advantage of similarity to humans in joint size, cartilage thickness and lesions (5). In addition, their bone tissue macro- and microstructure, composition, biochemical properties and mineral density are closer to humans (4,7,93). Of the large animal models, pigs are used most. As they are heavier than sheep and goats, the injury site bears a larger load and requires a longer evaluation period (17); however, satisfactory repair of osteochondral lesions is rarely achieved in large animals. Therefore, achievement of satisfactory osteochondral regeneration in large animal models could indicate potential strategies for further clinical work.
![]() | Table IV.Overview and characterization of experimental studies with a focus on alterations of the subchondral bone plate and osteochondral unit. |
It is necessary to establish standard criteria for animal models used in translational studies. Generally, the criteria for osteochondral defects include defect location, defect size (depth and diameter) and the age of the animal. At present, the creation of an osteochondral defect is based on the protocol used in small animal models, with the defects mostly located in the femoral trochlea, patellar trochlea and condyle of the femur (92,94). The induced defect is usually 2–4 mm in diameter and 3–6 mm deep; this depth can generally lead to formation of a full-scale osteochondral defect. Selected animals must have mature skeletons (92,94). Although several studies have reported osteochondral tissue regeneration using small animal models, use of these models has been restricted due to the major disparities between human and animal joints (92). By contrast, large animal model-based research is likely to be more useful in the future. Defects in large animal models are always induced in the condyle or trochlea of the femur (17). The defect diameter is usually 6–10 mm and the depth is also 6–10 mm, which generally reaches the depth of a full-scale osteochondral defect (92). Due to the similarities to human disease development and pathophysiological changes, large animal models are ideal for studying osteochondral defects. Future research should establish uniform standards for selecting animal models. First, large animals make more suitable models. Second, large animals are ideal for the choice of defect location; most human knee joint injuries occur on the femoral condyle, which is a suitable option for the defect site in the model (92) and the defect size must reach that of a full-scale osteochondral defect. Furthermore, adult animals should be used, which is consistent with the current trend of human disease; osteoarthritis is more common in elderly adults than in adolescents (8,11).
Challenges and perspectives
Previous studies have illustrated various failures in osteochondral transplants (30,33). Such unsatisfactory consequences comprise two main classifications: Functional failure and pathological abnormalities. The most perplexing findings for pathological abnormalities are the collapsed structure of the osteochondral unit (18). Cartilage hypertrophy, fibro tissue hyperplasia, concavity formation and inconsistency among phases (47) are common in osteochondral regeneration studies. Even structural collapsing directly indicates the functional failure of osteochondral transplants. Other pathological changes, such as cartilage hypertrophy, fibro tissue hyperplasia, cause difficulty for long maintenance.
In the complicated progression of osteochondral repair and design of transplants variation, it is difficult to explain a single failure in performance comprehensively. However, inherent deficiency for chondral regeneration and temporal disorder among chondral/osteo-regeneration have been attributed to the aforementioned pathological abnormalities and functional failures. Compositional and structural insufficient for neo formed cartilage are strongly associated with cartilage hypertrophy, fibro tissue hyperplasia and concavity formation. On the other hand, a relative earlier completion of bone tissue repair is equally important for reducing pathological abnormalities. Immunological rejection related insufficient interfacial integration is another potential reason for transplants failure (58).
Neo-formed SBP, with proper location and acceptable architecture, is used as a crucial standard to determine successful osteochondral regeneration. The present review summarized four common SBP pathological performances from previous studies with failed osteochondral regeneration including abnormal height, uneven surface, poor integration and loose internal structure. Abnormal height was the most common presentation of poor repair and markedly affected SBP reconstruction. With the help of our pathological classification, transplants failure interpretation may be possible for future studies.
To achieve satisfactory SBP during osteochondral regeneration, multi-layer TE grafts with a transition layer or calcified layer was introduced into current studies. However, graft layer quantity is limited to a certain extent. With the increase of the number of layers, the manufacturing cost gradually increases, as well as the difficulty of the fabrication techniques. However, the anticipated improvement in the ultimate repair has not been achieved (30,33), which is contrary to the concept of high efficiency and low consumption. The structure of gradient scaffolds is different from that of traditional layered scaffolds. The gradient grafts can obtain satisfactory osteochondral repair by virtue of its unique advantages. However, the shortcomings of the gradient scaffold cannot be ignored. Gradually changed components in the graft could not acquire the distinct regions at the defect site. In addition, the degradation rate of gradient scaffolds is faster than the stratified scaffolds (95) and such rapid degradation rate is not conducive to the load-bearing capacity of neo tissues at the defect site.
Tissue-engineered osteochondral grafts have promise for repairing osteochondral defects. Nonetheless, barriers remain throughout the translational process and must be overcome. First, the restrictive microenvironment in vitro may be a crucial factor in cultivating a successful graft, including appropriate culture medium, suitable temperature and sophisticated culture techniques (13). Second, because improper biomaterial selection may result in the premature collapse of the scaffold or, conversely, late degeneration, adaptive biomaterials may potentially be a barrier to further deployment (3). Multilayer graft with proper biomaterial to regenerate SBP is a promising way to obtain reasonable chronological order for chondral/osteo-regeneration. Third, the translational animal model selected also affects the repair results depending on such factors as species, age, defect location and defect geometry (96). Lack of a unified standard for translational animal types will lead to a biased interpretation of regeneration results. Security concerns and expense also limit the repair efficiency of tissue-engineered grafts. Although these grafts show promise for healing osteochondral lesions, several obstacles to successful clinical application remain; these obstacles may guide breakthroughs in the creation of new tissue engineering strategies (97–99).
There are also several limitations in current reviews. As the limited quantity of studies focus on SBP regeneration, the present study merely focused on the local regeneration of SBP, instead of establishing connection between SBP pathological changes and the regeneration of other parts. Second, the evaluation of SBP was based on histological and radiological performance. The summary of poor SBP repair was subjective and additional research is required to address this issue. Third, no conclusion for the TE graft with ideal SBP regeneration was drawn in the present review. Even multilayer scaffold with cocktail growth factors to promote SBP regeneration was suggested. Further study to provide proper biomaterials allowing fine control for chondral and osteo-portion regeneration as well as biocompatibility are required.
Conclusion
SBP is a new promising path to understand the osteochondral regeneration and to interpret osteochondral transplants destiny. In the present review, the histology of the SBP was discussed and four common histological manifestations of poor repair were established, including abnormal height, uneven surface, poor integration and loose internal structure. The impact of different tissue engineering graft designs on osteochondral unit repair was also discussed. Incorporating mesenchymal stem cells into trilayer/multilayer scaffolds, supplemented by appropriate growth factors, can produce satisfactory osteochondral unit repair. Moreover, the SBP has also been repaired. Finally, future studies should focus on large animal models given their physical similarities to humans; such models will inspire future clinical research on tissue-engineered grafts. This review has shed light on potential standards for the construction of future animal models of osteochondral defects.
Acknowledgements
Not applicable.
Funding
The present study was funded by Natural Science Foundation of Jilin Province (grant no. YDZJ202201ZYTS281)
Availability of data and materials
Not applicable.
Authors' contributions
MC and XZ made substantial contributions to the conception and design of the work. XZ, WJ, QD and YS drafted the manuscript. MC, XZ, WJ, QD and YS revised the manuscript critically for important intellectual content. Data authentication is not applicable. All authors read and approved the final manuscript. All co-authors agree to be accountable for all aspects of the work.
Ethics approval and consent to participate
Not applicable.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests
References
Francis SL, Di Bella C, Wallace GG and Choong PFM: Cartilage tissue engineering using stem cells and bioprinting technology-barriers to clinical translation. Front Surg. 5:702018. View Article : Google Scholar : PubMed/NCBI | |
Patel JM, Saleh KS, Burdick JA and Mauck RL: Bioactive factors for cartilage repair and regeneration: Improving delivery, retention, and activity. Acta Biomater. 93:222–238. 2019. View Article : Google Scholar : PubMed/NCBI | |
Zhou L, Gjvm VO, Malda J, Stoddart MJ, Lai Y, Richards RG, Ho KKW and Qin L: Innovative tissue-engineered strategies for osteochondral defect repair and regeneration: Current progress and challenges. Adv Healthc Mater. 9:e20010082020. View Article : Google Scholar : PubMed/NCBI | |
Jacob G, Shimomura K and Nakamura N: Osteochondral injury, management and tissue engineering approaches. Front Cell Dev Biol. 8:5808682020. View Article : Google Scholar : PubMed/NCBI | |
Spencer V, Illescas E, Maltes L, Kim H, Sathe V and Nukavarapu S: Osteochondral tissue engineering: Translational research and turning research into products. Adv Exp Med Biol. 1058:373–390. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yu H, Feng M, Mao G, Li Q, Zhang Z, Bian W and Qiu Y: Implementation of photosensitive, injectable, interpenetrating, and kartogenin-modified GELMA/PEDGA biomimetic scaffolds to restore cartilage integrity in a full-thickness osteochondral defect model. ACS Biomater Sci Eng. 8:4474–4485. 2022. View Article : Google Scholar : PubMed/NCBI | |
Kwon H, Brown WE, Lee CA, Wang D, Paschos N, Hu JC and Athanasiou KA: Surgical and tissue engineering strategies for articular cartilage and meniscus repair. Nat Rev Rheumatol. 15:550–570. 2019. View Article : Google Scholar : PubMed/NCBI | |
Maia FR, Carvalho MR, Oliveira JM and Reis RL: Tissue engineering strategies for osteochondral repair. Adv Exp Med Biol. 1059:353–371. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhao Z, Li J, Bai X, Wang Y, Wang Q, Lv N, Gao H, Guo Z, Zhu H, Guo Q and Li Z: Microfracture augmentation with direct in situ radial shockwave stimulation with appropriate energy has comparable repair Performance with tissue engineering in the porcine osteochondral defect model. Am J Sports Med. 50:3660–3670. 2022. View Article : Google Scholar : PubMed/NCBI | |
Yang J, Zhang YS, Yue K and Khademhosseini A: Cell-laden hydrogels for osteochondral and cartilage tissue engineering. Acta Biomater. 57:1–25. 2017. View Article : Google Scholar : PubMed/NCBI | |
Campos Y, Almirall A, Fuentes G, Bloem HL, Kaijzel EL and Cruz LJ: Tissue engineering: An alternative to repair cartilage. Tissue Eng Part B Rev. 25:357–373. 2019. View Article : Google Scholar : PubMed/NCBI | |
Kim YG, Choi J and Kim K: Mesenchymal stem cell-derived exosomes for effective cartilage tissue repair and treatment of osteoarthritis. Biotechnol J. 15:e20000822020. View Article : Google Scholar : PubMed/NCBI | |
Zhao Z, Fan C, Chen F, Sun Y, Xia Y, Ji A and Wang DA: Progress in articular cartilage tissue engineering: A review on therapeutic cells and macromolecular scaffolds. Macromol Biosci. 20:e19002782020. View Article : Google Scholar : PubMed/NCBI | |
Liu X, Meng H, Guo Q, Sun B, Zhang K, Yu W, Liu S, Wang Y, Jing X, Zhang Z, et al: Tissue-derived scaffolds and cells for articular cartilage tissue engineering: Characteristics, applications and progress. Cell Tissue Res. 372:13–22. 2018. View Article : Google Scholar : PubMed/NCBI | |
Hu Y, Chen X, Wang S, Jing Y and Su J: Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 9:202021. View Article : Google Scholar : PubMed/NCBI | |
Hu W, Chen Y, Dou C and Dong S: Microenvironment in subchondral bone: Predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 80:413–422. 2021. View Article : Google Scholar : PubMed/NCBI | |
Orth P and Madry H: Advancement of the subchondral bone plate in translational models of osteochondral repair: Implications for tissue engineering approaches. Tissue Eng Part B Rev. 21:504–520. 2015. View Article : Google Scholar : PubMed/NCBI | |
Critchley S, Sheehy EJ, Cunniffe G, Diaz-Payno P, Carroll SF, Jeon O, Alsberg E, Brama PAJ and Kelly DJ: 3D printing of fibre-reinforced cartilaginous templates for the regeneration of osteochondral defects. Acta Biomater. 113:130–143. 2020. View Article : Google Scholar : PubMed/NCBI | |
Mendes LF, Bosmans K, Van Hoven I, Viseu SR, Marechal M and Luyten FP: Developmental engineering of living implants for deep osteochondral joint surface defects. Bone. 139:1155202020. View Article : Google Scholar : PubMed/NCBI | |
Song H and Park KH: Regulation and function of SOX9 during cartilage development and regeneration. Semin Cancer Biol. 67:12–23. 2020. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Yu J, Ren K, Zuo J, Ding J and Chen X: Thermosensitive hydrogels as scaffolds for cartilage tissue engineering. Biomacromolecules. 20:1478–1492. 2019. View Article : Google Scholar : PubMed/NCBI | |
Lesage C, Lafont M, Guihard P, Weiss P, Guicheux J and Delplace V: Material-Assisted strategies for osteochondral defect repair. Adv Sci (Weinh). 9:e22000502022. View Article : Google Scholar : PubMed/NCBI | |
Lu J, Shen X, Sun X, Yin H, Yang S, Lu C, Wang Y, Liu Y, Huang Y, Yang Z, et al: Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration. Theranostics. 8:5039–5058. 2018. View Article : Google Scholar : PubMed/NCBI | |
Nie X, Yang J, Chuah YJ, Zhu W, Peck Y, He P and Wang DA: Full-Scale osteochondral regeneration by sole graft of tissue-engineered hyaline cartilage without co-engraftment of subchondral bone substitute. Adv Healthc Mater. 9:e19013042020. View Article : Google Scholar : PubMed/NCBI | |
Yu F, Li M, Yuan Z, Rao F, Fang X, Jiang B, Wen Y and Zhang P: Mechanism research on a bioactive resveratrol- PLA-gelatin porous nano-scaffold in promoting the repair of cartilage defect. Int J Nanomedicine. 13:7845–7858. 2018. View Article : Google Scholar : PubMed/NCBI | |
Mendes LF, Katagiri H, Tam WL, Chai YC, Geris L, Roberts SJ and Luyten FP: Advancing osteochondral tissue engineering: Bone morphogenetic protein, transforming growth factor, and fibroblast growth factor signaling drive ordered differentiation of periosteal cells resulting in stable cartilage and bone formation in vivo. Stem Cell Res Ther. 9:422018. View Article : Google Scholar : PubMed/NCBI | |
Xu D, Cheng G, Dai J and Li Z: Bi-layered composite scaffold for repair of the osteochondral defects. Adv Wound Care (New Rochelle). 10:401–414. 2021. View Article : Google Scholar : PubMed/NCBI | |
Liang X, Duan P, Gao J, Guo R, Qu Z, Li X, He Y, Yao H and Ding J: Bilayered PLGA/PLGA-HAp composite scaffold for osteochondral tissue engineering and tissue regeneration. ACS Biomater Sci Eng. 4:3506–3521. 2018. View Article : Google Scholar : PubMed/NCBI | |
Kim HS, Mandakhbayar N, Kim HW, Leong KW and Yoo HS: Protein-reactive nanofibrils decorated with cartilage-derived decellularized extracellular matrix for osteochondral defects. Biomaterials. 269:1202142021. View Article : Google Scholar : PubMed/NCBI | |
Zhang T, Zhang H, Zhang L, Jia S, Liu J, Xiong Z and Sun W: Biomimetic design and fabrication of multilayered osteochondral scaffolds by low-temperature deposition manufacturing and thermal-induced phase-separation techniques. Biofabrication. 9:0250212017. View Article : Google Scholar : PubMed/NCBI | |
Zhao Y, Ding X, Dong Y, Sun X, Wang L, Ma X, Zhu M, Xu B and Yang Q: Role of the calcified cartilage layer of an integrated trilayered silk fibroin scaffold used to regenerate osteochondral defects in rabbit knees. ACS Biomater Sci Eng. 6:1208–1216. 2020. View Article : Google Scholar : PubMed/NCBI | |
Huang Y, Fan H, Gong X, Yang L and Wang F: Scaffold with natural calcified cartilage zone for osteochondral defect repair in minipigs. Am J Sports Med. 49:1883–1891. 2021. View Article : Google Scholar : PubMed/NCBI | |
Chen T, Bai J, Tian J, Huang P, Zheng H and Wang J: A single integrated osteochondral in situ composite scaffold with a multi-layered functional structure. Colloids Surf B Biointerfaces. 167:354–363. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhai C, Fei H, Hu J, Wang Z, Xu S, Zuo Q, Li Z, Wang Z, Liang W and Fan W: Repair of articular osteochondral defects using an integrated and biomimetic trilayered scaffold. Tissue Eng Part A. 24:1680–1692. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yin H, Wang Y, Sun X, Cui G, Sun Z, Chen P, Xu Y, Yuan X, Meng H, Xu W, et al: Functional tissue-engineered microtissue derived from cartilage extracellular matrix for articular cartilage regeneration. Acta Biomater. 77:127–141. 2018. View Article : Google Scholar : PubMed/NCBI | |
Xue J, He A, Zhu Y, Liu Y, Li D, Yin Z, Zhang W, Liu W, Cao Y and Zhou G: Repair of articular cartilage defects with acellular cartilage sheets in a swine model. Biomed Mater. 13:0250162018. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Feng G, Xu G and Qi Y: Microporous acellular extracellular matrix combined with adipose-derived stem cell sheets as a promising tissue patch promoting articular cartilage regeneration and interface integration. Cytotherapy. 21:856–869. 2019. View Article : Google Scholar : PubMed/NCBI | |
Zhu S, Chen P, Chen Y, Li M, Chen C and Lu H: 3D-Printed extracellular matrix/polyethylene glycol diacrylate hydrogel incorporating the anti-inflammatory phytomolecule honokiol for regeneration of osteochondral defects. Am J Sports Med. 48:2808–2818. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wang Z, Li Z, Li Z, Wu B, Liu Y and Wu W: Cartilaginous extracellular matrix derived from decellularized chondrocyte sheets for the reconstruction of osteochondral defects in rabbits. Acta Biomater. 81:129–145. 2018. View Article : Google Scholar : PubMed/NCBI | |
Bahrami N, Bordbar S, Hasanzadeh E, Goodarzi A, Ai A and Mohamadnia A: The effect of decellularized cartilage matrix scaffolds combined with endometrial stem cell-derived osteocytes on osteochondral tissue engineering in rats. In Vitro Cell Dev Biol Anim. 58:480–490. 2022. View Article : Google Scholar : PubMed/NCBI | |
Zhang W, Zhang Y, Zhang A, Ling C, Sheng R, Li X, Yao Q and Chen J: Enzymatically crosslinked silk-nanosilicate reinforced hydrogel with dual-lineage bioactivity for osteochondral tissue engineering. Mater Sci Eng C Mater Biol Appl. 127:1122152021. View Article : Google Scholar : PubMed/NCBI | |
Feng X, Xu P, Shen T, Zhang Y, Ye J and Gao C: Influence of pore architectures of silk fibroin/collagen composite scaffolds on the regeneration of osteochondral defects in vivo. J Mater Chem B. 8:391–405. 2020. View Article : Google Scholar : PubMed/NCBI | |
Salonius E, Muhonen V, Lehto K, Järvinen E, Pyhältö T, Hannula M, Aula AS, Uppstu P, Haaparanta AM, Rosling A, et al: Gas-foamed poly(lactide-co-glycolide) and poly(lactide-co-glycolide) with bioactive glass fibres demonstrate insufficient bone repair in lapine osteochondral defects. J Tissue Eng Regen Med. 13:406–415. 2019. View Article : Google Scholar : PubMed/NCBI | |
Petrovova E, Tomco M, Holovska K, Danko J, Kresakova L, Vdoviakova K, Simaiova V, Kolvek F, Hornakova P, Toth T, et al: PHB/CHIT scaffold as a promising biopolymer in the treatment of osteochondral defects-an experimental animal study. Polymers (Basel). 13:12322021. View Article : Google Scholar : PubMed/NCBI | |
Zhou F, Zhang X, Cai D, Li J, Mu Q, Zhang W, Zhu S, Jiang Y, Shen W, Zhang S and Ouyang HW: Silk fibroin-chondroitin sulfate scaffold with immuno-inhibition property for articular cartilage repair. Acta Biomater. 63:64–75. 2017. View Article : Google Scholar : PubMed/NCBI | |
Kabirkoohian A, Bakhshi H, Irani S and Sharifi F: Chemical immobilization of carboxymethyl chitosan on polycaprolactone nanofibers as osteochondral scaffolds. Appl Biochem Biotechnol. 195:3888–3899. 2022. View Article : Google Scholar : PubMed/NCBI | |
Liu X, Yang Y, Li Y, Niu X, Zhao B, Wang Y, Bao C, Xie Z, Lin Q and Zhu L: Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. Nanoscale. 9:4430–4438. 2017. View Article : Google Scholar : PubMed/NCBI | |
Zuo Q, Cui W, Liu F, Wang Q, Chen Z and Fan W: Utilizing tissue-engineered cartilage or BMNC-PLGA composites to fill empty spaces during autologous osteochondral mosaicplasty in porcine knees. J Tissue Eng Regen Med. 10:916–926. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wang X, Song X, Li T, Chen J, Cheng G, Yang L and Chen C: Aptamer-Functionalized bioscaffold enhances cartilage repair by improving stem cell recruitment in osteochondral defects of rabbit knees. Am J Sports Med. 47:2316–2326. 2019. View Article : Google Scholar : PubMed/NCBI | |
He A, Liu L, Luo X, Liu Y, Liu Y, Liu F, Wang X, Zhang Z, Zhang W, Liu W, et al: Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model. Sci Rep. 7:404892017. View Article : Google Scholar : PubMed/NCBI | |
Perez-Silos V, Moncada-Saucedo NK, Pena-Martinez V, Lara-Arias J, Marino-Martínez IA, Camacho A, Romero-Díaz VJ, Banda ML, García-Ruiz A, Soto-Dominguez A, et al: A cellularized biphasic implant based on a bioactive silk fibroin promotes integration and tissue organization during osteochondral defect repair in a porcine model. Int J Mol Sci. 20:51452019. View Article : Google Scholar : PubMed/NCBI | |
Wang KH, Wan R, Chiu LH, Tsai YH, Fang CL, Bowley JF, Chen KC, Shih HN and Lai W: Effects of collagen matrix and bioreactor cultivation on cartilage regeneration of a full-thickness critical-size knee joint cartilage defects with subchondral bone damage in a rabbit model. PLoS One. 13:e01967792018. View Article : Google Scholar : PubMed/NCBI | |
Yan J, Liu C, Tu C, Zhang R, Tang X, Li H, Wang H, Ma Y, Zhang Y, Wu H and Sheng G: Hydrogel-hydroxyapatite-monomeric collagen type-I scaffold with low-frequency electromagnetic field treatment enhances osteochondral repair in rabbits. Stem Cell Res Ther. 12:5722021. View Article : Google Scholar : PubMed/NCBI | |
Xing J, Peng X, Li A, Chen M, Ding Y, Xu X, Yu P, Xie J and Li J: Gellan gum/alginate-based Ca-enriched acellular bilayer hydrogel with robust interface bonding for effective osteochondral repair. Carbohydr Polym. 270:1183822021. View Article : Google Scholar : PubMed/NCBI | |
Shen T, Dai Y, Li X, Xu S, Gou Z and Gao C: Regeneration of the osteochondral defect by a wollastonite and macroporous fibrin biphasic scaffold. ACS Biomater Sci Eng. 4:1942–1953. 2018. View Article : Google Scholar : PubMed/NCBI | |
Lin D, Cai B, Wang L, Cai L, Wang Z, Xie J, Lv QX, Yuan Y, Liu C and Shen SG: A viscoelastic PEGylated poly(glycerol sebacate)-based bilayer scaffold for cartilage regeneration in full-thickness osteochondral defect. Biomaterials. 253:1200952020. View Article : Google Scholar : PubMed/NCBI | |
Kumai T, Yui N, Yatabe K, Sasaki C, Fujii R, Takenaga M, Fujiya H, Niki H and Yudoh K: A novel, self-assembled artificial cartilage-hydroxyapatite conjugate for combined articular cartilage and subchondral bone repair: Histopathological analysis of cartilage tissue engineering in rat knee joints. Int J Nanomedicine. 14:1283–1298. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ruan SQ, Yan L, Deng J, Huang WL and Jiang DM: Preparation of a biphase composite scaffold and its application in tissue engineering for femoral osteochondral defects in rabbits. Int Orthop. 41:1899–1908. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wu Y, Yang Z, Denslin V, Ren X, Lee CS, Yap FL and Lee EH: Repair of osteochondral defects with predifferentiated mesenchymal stem cells of distinct phenotypic character derived from a nanotopographic platform. Am J Sports Med. 48:1735–1747. 2020. View Article : Google Scholar : PubMed/NCBI | |
Lin TH, Wang HC, Cheng WH, Hsu HC and Yeh ML: Osteochondral tissue regeneration using a tyramine-modified bilayered PLGA scaffold combined with articular chondrocytes in a porcine model. Int J Mol Sci. 20:3262019. View Article : Google Scholar : PubMed/NCBI | |
Browe DC, Diaz-Payno PJ, Freeman FE, Schipani R, Burdis R, Ahern DP, Nulty JM, Guler S, Randall LD, Buckley CT, et al: Bilayered extracellular matrix derived scaffolds with anisotropic pore architecture guide tissue organization during osteochondral defect repair. Acta Biomater. 143:266–281. 2022. View Article : Google Scholar : PubMed/NCBI | |
Seong YJ, Kang IG, Song EH, Kim HE and Jeong SH: Calcium phosphate-collagen scaffold with aligned pore channels for enhanced osteochondral regeneration. Adv Healthc Mater. 6:242017. View Article : Google Scholar : PubMed/NCBI | |
Ding X, Gao J, Yu X, Shi J, Chen J, Yu L, Chen S and Ding J: 3D-Printed porous scaffolds of hydrogels modified with TGF-β1 binding peptides to promote in vivo cartilage regeneration and animal gait restoration. ACS Appl Mater Interfaces. 14:15982–15995. 2022. View Article : Google Scholar : PubMed/NCBI | |
Gao J, Ding X, Yu X, Chen X, Zhang X, Cui S, Shi J, Chen J, Yu L, Chen S and Ding J: Cell-Free bilayered porous scaffolds for osteochondral regeneration fabricated by continuous 3D-printing using nascent physical hydrogel as ink. Adv Healthc Mater. 10:e20014042021. View Article : Google Scholar : PubMed/NCBI | |
Wei X, Liu B, Liu G, Yang F, Cao F, Dou X, Yu W, Wang B, Zheng G, Cheng L, et al: Mesenchymal stem cell-loaded porous tantalum integrated with biomimetic 3D collagen-based scaffold to repair large osteochondral defects in goats. Stem Cell Res Ther. 10:722019. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Ling C, Chen J, Liu H, Mo Q, Zhang W and Yao Q: 3D-printed composite scaffold with gradient structure and programmed biomolecule delivery to guide stem cell behavior for osteochondral regeneration. Biomater Adv. 140:2130672022. View Article : Google Scholar : PubMed/NCBI | |
Fang J, Liao J, Zhong C, Lu X and Ren F: High-Strength, biomimetic functional chitosan-based hydrogels for full-thickness osteochondral defect repair. ACS Biomater Sci Eng. 8:4449–4461. 2022. View Article : Google Scholar : PubMed/NCBI | |
Steele JAM, Moore AC, St-Pierre JP, McCullen SD, Gormley AJ, Horgan CC, Black CR, Meinert C, Klein T, Saifzadeh S, et al: In vitro and in vivo investigation of a zonal microstructured scaffold for osteochondral defect repair. Biomaterials. 286:1215482022. View Article : Google Scholar : PubMed/NCBI | |
Li M, Song P, Wang W, Xu Y, Li J, Wu L, Gui X, Zeng Z, Zhou Z, Liu M, et al: Preparation and characterization of biomimetic gradient multi-layer cell-laden scaffolds for osteochondral integrated repair. J Mater Chem B. 10:4172–4188. 2022. View Article : Google Scholar : PubMed/NCBI | |
Nie X, Chuah YJ, He P and Wang DA: Engineering a multiphasic, integrated graft with a biologically developed cartilage-bone interface for osteochondral defect repair. J Mater Chem B. 7:6515–6525. 2019. View Article : Google Scholar : PubMed/NCBI | |
Orth P, Cucchiarini M, Kaul G, Ong MF, Gräber S, Kohn DM and Madry H: Temporal and spatial migration pattern of the subchondral bone plate in a rabbit osteochondral defect model. Osteoarthritis Cartilage. 20:1161–1169. 2012. View Article : Google Scholar : PubMed/NCBI | |
Findlay DM and Kuliwaba JS: Bone-cartilage crosstalk: A conversation for understanding osteoarthritis. Bone Res. 4:160282016. View Article : Google Scholar : PubMed/NCBI | |
Nordberg RC, Huebner P, Schuchard KG, Mellor LF, Shirwaiker RA, Loboa EG and Spang JT: The evaluation of a multiphasic 3D-bioplotted scaffold seeded with adipose derived stem cells to repair osteochondral defects in a porcine model. J Biomed Mater Res B Appl Biomater. 109:2246–2258. 2021. View Article : Google Scholar : PubMed/NCBI | |
Yucekul A, Ozdil D, Kutlu NH, Erdemli E, Aydin HM and Doral MN: Tri-layered composite plug for the repair of osteochondral defects: In vivo study in sheep. J Tissue Eng. 8:20417314176975002017. View Article : Google Scholar : PubMed/NCBI | |
Qiao Z, Lian M, Han Y, Sun B, Zhang X, Jiang W, Li H, Hao Y and Dai K: Bioinspired stratified electrowritten fiber-reinforced hydrogel constructs with layer-specific induction capacity for functional osteochondral regeneration. Biomaterials. 266:1203852021. View Article : Google Scholar : PubMed/NCBI | |
Jia S, Wang J, Zhang T, Pan W, Li Z, He X, Yang C, Wu Q, Sun W, Xiong Z and Hao D: Multilayered scaffold with a compact interfacial layer enhances osteochondral defect repair. ACS Appl Mater Interfaces. 10:20296–20305. 2018. View Article : Google Scholar : PubMed/NCBI | |
Du Y, Liu H, Yang Q, Wang S, Wang J, Ma J, Noh I, Mikos AG and Zhang S: Selective laser sintering scaffold with hierarchical architecture and gradient composition for osteochondral repair in rabbits. Biomaterials. 137:37–48. 2017. View Article : Google Scholar : PubMed/NCBI | |
Jiang LB, Su DH, Liu P, Ma YQ, Shao ZZ and Dong J: Shape-memory collagen scaffold for enhanced cartilage regeneration: Native collagen versus denatured collagen. Osteoarthritis Cartilage. 26:1389–1399. 2018. View Article : Google Scholar : PubMed/NCBI | |
Parisi C, Salvatore L, Veschini L, Serra MP, Hobbs C, Madaghiele M, Sannino A and Di Silvio L: Biomimetic gradient scaffold of collagen-hydroxyapatite for osteochondral regeneration. J Tissue Eng. 11:20417314198960682020. View Article : Google Scholar : PubMed/NCBI | |
Asensio G, Benito-Garzon L, Ramirez-Jimenez RA, Guadilla Y, Gonzalez-Rubio J, Abradelo C, Parra J, Martín-López MR, Aguilar MR, Vázquez-Lasa B and Rojo L: Biomimetic gradient scaffolds containing hyaluronic acid and Sr/Zn folates for osteochondral tissue engineering. Polymers (Basel). 14:122021. View Article : Google Scholar : PubMed/NCBI | |
Idaszek J, Costantini M, Karlsen TA, Jaroszewicz J, Colosi C, Testa S, Fornetti E, Bernardini S, Seta M, Kasarełło K, et al: 3D bioprinting of hydrogel constructs with cell and material gradients for the regeneration of full-thickness chondral defect using a microfluidic printing head. Biofabrication. 11:0441012019. View Article : Google Scholar : PubMed/NCBI | |
Oshima T, Nakase J, Toratani T, Numata H, Takata Y, Nakayama K and Tsuchiya H: A scaffold-free allogeneic construct from adipose-derived stem cells regenerates an osteochondral defect in a rabbit model. Arthroscopy. 35:583–593. 2019. View Article : Google Scholar : PubMed/NCBI | |
Yuan Z, Lyu Z, Zhang W, Zhang J and Wang Y: Porous bioactive prosthesis with Chitosan/Mesoporous silica nanoparticles microspheres sequentially and sustainedly releasing platelet-derived growth factor-BB and kartogenin: A new treatment strategy for osteoarticular lesions. Front Bioeng Biotechnol. 10:8391202022. View Article : Google Scholar : PubMed/NCBI | |
Gupta V, Lyne DV, Laflin AD, Zabel TA, Barragan M, Bunch JT, Pacicca DM and Detamore MS: Microsphere-based osteochondral scaffolds carrying opposing gradients of decellularized cartilage and demineralized bone matrix. ACS Biomater Sci Eng. 3:1955–1963. 2016. View Article : Google Scholar : PubMed/NCBI | |
Gu X, Zha Y, Li Y, Chen J, Liu S, Du Y, Zhang S and Wang J: Integrated polycaprolactone microsphere-based scaffolds with biomimetic hierarchy and tunable vascularization for osteochondral repair. Acta Biomater. 141:190–197. 2022. View Article : Google Scholar : PubMed/NCBI | |
Qasim M, Chae DS and Lee NY: Bioengineering strategies for bone and cartilage tissue regeneration using growth factors and stem cells. J Biomed Mater Res A. 108:394–411. 2020. View Article : Google Scholar : PubMed/NCBI | |
Chen L, Liu J, Guan M, Zhou T, Duan X and Xiang Z: growth factor and its polymer scaffold-based delivery system for cartilage tissue engineering. Int J Nanomedicine. 15:6097–6111. 2020. View Article : Google Scholar : PubMed/NCBI | |
Kazemi M and Williams JL: Properties of cartilage-subchondral bone junctions: A narrative review with specific focus on the growth plate. Cartilage. 13:16S–33S. 2021. View Article : Google Scholar : PubMed/NCBI | |
Sun J, Lyu J, Xing F, Chen R, Duan X and Xiang Z: A biphasic, demineralized, and Decellularized allograft bone-hydrogel scaffold with a cell-based BMP-7 delivery system for osteochondral defect regeneration. J Biomed Mater Res A. 108:1909–1921. 2020. View Article : Google Scholar : PubMed/NCBI | |
Bothe F, Deubel AK, Hesse E, Lotz B, Groll J, Werner C, Richter W and Hagmann S: Treatment of focal cartilage defects in minipigs with zonal chondrocyte/mesenchymal progenitor cell constructs. Int J Mol Sci. 20:6532019. View Article : Google Scholar : PubMed/NCBI | |
Chen L, Wei L, Su X, Qin L, Xu Z, Huang X, Chen H and Hu N: Preparation and characterization of biomimetic functional scaffold with gradient structure for osteochondral defect repair. Bioengineering (Basel). 10:2132023. View Article : Google Scholar : PubMed/NCBI | |
Hurtig MB, Buschmann MD, Fortier LA, Hoemann CD, Hunziker EB, Jurvelin JS, Mainil-Varlet P, McIlwraith CW, Sah RL and Whiteside RA: Preclinical studies for cartilage repair. Cartilage. 2:137–152. 2011. View Article : Google Scholar : PubMed/NCBI | |
Confalonieri D, Schwab A, Walles H and Ehlicke F: Advanced therapy medicinal products: A guide for bone marrow-derived MSC application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 24:155–169. 2018. View Article : Google Scholar : PubMed/NCBI | |
Dargoush SA, Hanaee-Ahvaz H, Irani S, Soleimani M, Khatami SM and Sohi AN: A composite bilayer scaffold functionalized for osteochondral tissue regeneration in rat animal model. J Tissue Eng Regen Med. 16:559–574. 2022. View Article : Google Scholar : PubMed/NCBI | |
Aisenbrey EA, Tomaschke A, Kleinjan E, Muralidharan A, Pascual-Garrido C, McLeod RR, Ferguson VL and Bryant SJ: A stereolithography-based 3D printed hybrid scaffold for in situ cartilage defect repair. Macromol Biosci. 18:10.1002/mabi.201700267. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zlotnick HM, Locke RC, Hemdev S, Stoeckl BD, Gupta S, Peredo AP, Steinberg DR, Carey JL, Lee D, Dodge GR and Mauck RL: Gravity-based patterning of osteogenic factors to preserve bone structure after osteochondral injury in a large animal model. Biofabrication. 14:10.1088/1758–5090/ac79cd. 2022. View Article : Google Scholar | |
Zhang J, Zhang D, Wu C, Liu A, Zhang C, Jiao J and Shang M: Icariin-conditioned serum engineered with hyaluronic acid promote repair of articular cartilage defects in rabbit knees. BMC Complement Altern Med. 19:1552019. View Article : Google Scholar : PubMed/NCBI | |
Xiao SP, Tang LS, Chen JY, Li ZT, Cheng GH, Chen QQ, Liu SH and Liu WG: Effect of cross-linked hyaluronate scaffold on cartilage repair: An in vivo study. Orthop Surg. 11:679–689. 2019. View Article : Google Scholar : PubMed/NCBI | |
Korthagen NM, Brommer H, Hermsen G, Plomp SGM, Melsom G, Coeleveld K, Mastbergen SC, Weinans H, van Buul W and van Weeren PR: A short-term evaluation of a thermoplastic polyurethane implant for osteochondral defect repair in an equine model. Vet J. 251:1053402019. View Article : Google Scholar : PubMed/NCBI |